OCULAR HYPERTENSION

This study is testing if a tiny, slow-release implant placed in the eye during cataract surgery works as well as daily eye drops to lower eye pressure in people with mild to moderate glaucoma. About 400 people who need cataract surgery and have glaucoma will be randomly assigned …

This study is testing a new eye drop called HUC3-637 for people with a common type of glaucoma or high eye pressure. It aims to see if it works as well as or better than an existing standard treatment at lowering pressure inside the eye. The trial will involve 206 adults and is i…

This study is testing a laser procedure called DSLT to see if it can safely lower eye pressure in Chinese patients with different types of glaucoma. The goal is to control the disease and potentially reduce the need for daily eye drop medications. About 45 participants will recei…

This study is testing a new, slow-release implant called AGN-193408 SR that is placed inside the eye. The goal is to see if it can safely and effectively lower eye pressure for people with open-angle glaucoma or ocular hypertension, potentially reducing the need for daily eye dro…

This study compares two prescription eye drops to see which one better controls eye pressure over a full 24-hour period in people with glaucoma or high eye pressure. Thirty adults will use one drop in each eye nightly for two weeks while researchers measure pressure changes day a…

This study is testing a small, slow-release implant placed in the eye during routine cataract surgery. It aims to lower eye pressure in people with mild to moderate glaucoma or high eye pressure. The implant is being compared to standard daily eye drops to see if it is as safe an…

This study is testing if a long-acting eye implant (Durysta) can help people with glaucoma who use daily eye drops. The goal is to see if the implant reduces the number of drops needed and lessens eye surface inflammation and discomfort. Researchers will measure inflammation leve…

This study is testing a laser procedure called DSLT to see if it can help people with controlled glaucoma or high eye pressure use fewer daily eye drop medications. The procedure aims to improve fluid drainage in the eye. Researchers will follow 60 participants for 6 months to se…

This study aims to test an artificial intelligence (AI) eye screening program in community health centers that serve low-income and uninsured patients. It will screen 1,800 adults at risk for glaucoma, diabetic retinopathy, cataracts, or vision problems to see if the program effe…